Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 34
2010 316
2011 50
2013 1
2015 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

316 results
Results by year
Filters applied: . Clear all
Page 1
Motor neuron diversity in development and disease.
Kanning KC, Kaplan A, Henderson CE. Kanning KC, et al. Annu Rev Neurosci. 2010;33:409-40. doi: 10.1146/annurev.neuro.051508.135722. Annu Rev Neurosci. 2010. PMID: 20367447 Review.
Although often considered as a group, spinal motor neurons are highly diverse in terms of their morphology, connectivity, and functional properties and differ significantly in their response to disease. ...For example, glial cell line-derived neurotrophic factor (GDNF) has …
Although often considered as a group, spinal motor neurons are highly diverse in terms of their morphology, connectivity, and functio …
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.
Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, Le TT, Morales PR, Rich MM, Burghes AH, Kaspar BK. Foust KD, et al. Nat Biotechnol. 2010 Mar;28(3):271-4. doi: 10.1038/nbt.1610. Epub 2010 Feb 28. Nat Biotechnol. 2010. PMID: 20190738 Free PMC article.
Spinal muscular atrophy (SMA), the most common autosomal recessive neurodegenerative disease affecting children, results in impaired motor neuron function. ...
Spinal muscular atrophy (SMA), the most common autosomal recessive neurodegenerative disease affecting children, result
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.
Hua Y, Sahashi K, Hung G, Rigo F, Passini MA, Bennett CF, Krainer AR. Hua Y, et al. Genes Dev. 2010 Aug 1;24(15):1634-44. doi: 10.1101/gad.1941310. Epub 2010 Jul 12. Genes Dev. 2010. PMID: 20624852 Free PMC article.
Increasing survival of motor neuron 2, centromeric (SMN2) exon 7 inclusion to express more full-length SMN protein in motor neurons is a promising approach to treat spinal muscular atrophy (SMA), a genetic neurodegenerative disease. ...Using a micro-osmotic p …
Increasing survival of motor neuron 2, centromeric (SMN2) exon 7 inclusion to express more full-length SMN protein in motor neurons is a pro …
Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure.
Aagaard P, Suetta C, Caserotti P, Magnusson SP, Kjaer M. Aagaard P, et al. Scand J Med Sci Sports. 2010 Feb;20(1):49-64. doi: 10.1111/j.1600-0838.2009.01084.x. Scand J Med Sci Sports. 2010. PMID: 20487503 Review.
Aging is characterized by loss of spinal motor neurons (MNs) due to apoptosis, reduced insulin-like growth factor I signaling, elevated amounts of circulating cytokines, and increased cell oxidative stress. The age-related loss of spinal MNs is paralleled by a reduc …
Aging is characterized by loss of spinal motor neurons (MNs) due to apoptosis, reduced insulin-like growth factor I signaling, elevat …
TRPV4-mediated channelopathies.
Verma P, Kumar A, Goswami C. Verma P, et al. Channels (Austin). 2010 Jul-Aug;4(4):319-28. doi: 10.4161/chan.4.4.12905. Epub 2010 Jul 6. Channels (Austin). 2010. PMID: 20676052 Review.
Recently it gained immense medical and clinical interest as several independent studies have demonstrated that mutations in the TRPV4 gene can results in genetic disorders like Brachyolmia, Charcot-Marie-Tooth disease type 2C, Spinal Muscular Atrophy and Here …
Recently it gained immense medical and clinical interest as several independent studies have demonstrated that mutations in the TRPV4 gene c …
Spinal muscular atrophy: diagnosis, treatment and future prospects.
Baioni MT, Ambiel CR. Baioni MT, et al. J Pediatr (Rio J). 2010 Jul-Aug;86(4):261-70. doi: 10.2223/JPED.1988. J Pediatr (Rio J). 2010. PMID: 20711542 Free article. Review. English, Portuguese.
OBJECTIVE: To report on recent genetic and molecular discoveries and on future prospects for the treatment of spinal muscular atrophy (SMA), thereby helping healthcare professionals to make a quick diagnosis and provide appropriate and timely therapeutic supp …
OBJECTIVE: To report on recent genetic and molecular discoveries and on future prospects for the treatment of spinal muscular
Carrier testing for spinal muscular atrophy.
Gitlin JM, Fischbeck K, Crawford TO, Cwik V, Fleischman A, Gonye K, Heine D, Hobby K, Kaufmann P, Keiles S, MacKenzie A, Musci T, Prior T, Lloyd-Puryear M, Sugarman EA, Terry SF, Urv T, Wang C, Watson M, Yaron Y, Frosst P, Howell RR. Gitlin JM, et al. Genet Med. 2010 Oct;12(10):621-2. doi: 10.1097/GIM.0b013e3181ef6079. Genet Med. 2010. PMID: 20808230 Free PMC article.
Spinal muscular atrophy is the most common fatal hereditary disease among newborns and infants. ...In this article, the meeting participants summarize the discussions and conclude that pan-ethnic carrier screening for spinal muscular atrophy
Spinal muscular atrophy is the most common fatal hereditary disease among newborns and infants. ...In this article, the
Perspectives and diagnostic considerations in spinal muscular atrophy.
Prior TW. Prior TW. Genet Med. 2010 Mar;12(3):145-52. doi: 10.1097/GIM.0b013e3181c5e713. Genet Med. 2010. PMID: 20057317 Review.
Spinal muscular atrophy is an autosomal recessive neurodegenerative disease and the most common genetic cause of infant mortality. The disease results in motor neuron loss and skeletal muscle atrophy. Spinal muscular atrophy is cau
Spinal muscular atrophy is an autosomal recessive neurodegenerative disease and the most common genetic cause of infant
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability.
Glanzman AM, Mazzone E, Main M, Pelliccioni M, Wood J, Swoboda KJ, Scott C, Pane M, Messina S, Bertini E, Mercuri E, Finkel RS. Glanzman AM, et al. Neuromuscul Disord. 2010 Mar;20(3):155-61. doi: 10.1016/j.nmd.2009.11.014. Epub 2010 Jan 13. Neuromuscul Disord. 2010. PMID: 20074952 Free PMC article.
The motor skills of patients with spinal muscular atrophy, type I (SMA-I) are very limited. It is difficult to quantify the motor abilities of these patients and as a result there is currently no validated measure of motor function that can be utilized as an …
The motor skills of patients with spinal muscular atrophy, type I (SMA-I) are very limited. It is difficult to quantify …
Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA).
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G. Katsuno M, et al. Adv Exp Med Biol. 2010;685:64-74. doi: 10.1007/978-1-4419-6448-9_6. Adv Exp Med Biol. 2010. PMID: 20687495 Review.
Spinal and bulbar muscular atrophy (SBMA) is an adult-onset neurodegenerative disease characterized by slowly progressive muscle weakness and atrophy. ...SBMA exclusively occurs in adult males, whereas both heterozygous and homozygous females are usual
Spinal and bulbar muscular atrophy (SBMA) is an adult-onset neurodegenerative disease characterized by slowly progressi
316 results